Mersana Therapeutics (NASDAQ:MRSN) Trading 4.7% Higher

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Rating)’s stock price traded up 4.7% during mid-day trading on Thursday . The stock traded as high as $4.48 and last traded at $4.48. 1,401,726 shares were traded during mid-day trading, an increase of 7% from the average session volume of 1,304,263 shares. The stock had previously closed at […]

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,Brian Deschuytner ,Anna Protopapas ,Mikhail Papisov ,Upifitamab Rilsodotin Upri ,Citigroup ,Mersana Therapeutics Company Profile ,Virtu Financial ,Advisors Inc ,Securities Exchange Commission ,Mersana Therapeutics Inc ,Nasdaq ,Life Insurance Co ,Jpmorgan Chase Co ,Mersana Therapeutics ,Get Rating ,Exchange Commission ,Upifitamab Rilsodotin ,Mersana Therapeutics Daily ,Nasdaq Mrsn ,Mrsn ,Medical ,Stocks ,Technicals ,